Back
United Therapeutics Stock Predictions
Free, 30-minute video on trading overnight options for big gains
Get access to this 30-minute training free here.
Buy
52
UTHR
United Therapeutics
Last Price:
310.85
Seasonality Move:
6.85%
7 Day Trial
ALL ACCESS PASS
$
7
Nvidia's march to $5 trillion
Click here to see how Nvidia's march to $5 trillion could impact its partners.United Therapeutics Stock Forecast
- Over the next 52 weeks, United Therapeutics has on average historically risen by 19.4% based on the past 25 years of stock performance.
- United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
-
Is United Therapeutics Stock Undervalued?
The current United Therapeutics [UTHR] share price is $311.04. The Score for UTHR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. - UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, United Therapeutics has on average historically risen by 19.4% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
52
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
- United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
325.00
52-Week Low:
208.62
Prediction Charts
Market Cap:
13.8B
Price in USD:
311.04
Volume:
281.24K
Beta:
0.53
Technical Analysis
SMA50:
277.46
SMA100:
254.61
SMA200:
240.77
52-Wk Change:
39.01%
Stock Predictions
-
Is United Therapeutics stock public?
Yes, United Therapeutics is a publicly traded company. -
What is the United Therapeutics stock quote today?
The United Therapeutics stock price is 311.04 USD today. -
How to buy United Therapeutics stock online?
You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jun-13 | 280.29 | 287.67 | 288.35 | 279.31 |
| Jun-14 | 285.83 | 288.06 | 288.83 | 285.72 |
| Jun-17 | 286.92 | 297.06 | 297.70 | 285.27 |
| Jun-18 | 298.02 | 306.04 | 306.78 | 297.30 |
| Jun-20 | 305.77 | 308.98 | 311.30 | 302.71 |
| Jun-21 | 311.07 | 316.00 | 317.46 | 308.08 |
| Jun-24 | 316.04 | 318.78 | 320.21 | 308.69 |
| Jun-25 | 318.59 | 319.04 | 321.80 | 316.67 |
| Jun-26 | 318.78 | 318.98 | 321.07 | 314.76 |
| Jun-27 | 317.19 | 316.93 | 319.12 | 313.04 |
| Jun-28 | 319.11 | 318.66 | 321.45 | 315.60 |
| Jul-1 | 317.27 | 319.01 | 325.00 | 315.45 |
| Jul-2 | 318.00 | 317.05 | 320.07 | 314.87 |
| Jul-3 | 318.00 | 311.04 | 318.00 | 309.04 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.83 per share, and an increase next year of $1.72 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.